New Price Target for PAOG

On the heels of updated reporting and strong technicals, we are introducing a new 12 month price target for PAO Group (OTC - PAOG - NR) that is nearly 5x its current stock price.

Read more...
 
The Next Major COVID-19 Player

In our view, Global Wholehealth Partners Corp. (OTC - GWHP – NR) is positioned to emerge as the next major COVID-19 diagnostics company.

Read more...
 
Under the Radar CBD Pharma Player Could Offer Major Upside

Following the close of strategic acquisitions, emerging CBD Pharma company PAO Group, Inc. (OTC - PAOG - NR) is a company to watch closely as it could enjoy a major rise in value as it completes key milestones.

Read more...
 
Vet Health Enjoying Major Growth

See why PetVivo (OTC - PETV) has the best valuation and upside in the industry.

Read more...
 
ELECTRIC VEHICLES MARKET IS POWERING UP

Given the huge runs electric vehicle (EV) stocks have made of late we elected to draft an EV industry snapshot and highlight the space and key companies, including low price alternatives to Tesla (NASDAQ – TSLA) such as Alternet Systems (OTC – ALYI – Spec Buy)..

Read more...
 
PETV Gaining Momentum in Pet Therapeutics Market

PETV is well-positioned to emerge as the standard of care for the treatment of osteoarthritis in dogs and horses, an unmet need representing an estimated $3.2B market.

Read more...
 
CBDL: A Play on Pet CBD Wellness and More

CBD Life Sciences, Inc. (OTC – CBDL) is not your typical CBD company. With a robust online business, brick and mortar location, combined with a diverse offering in key, in-demand categories, CBDL is poised to continue to generate strong sales growth ahead.

Read more...
 
PLIN: New M&A Plus JV Equals Higher Forecasts, Price

In a matter of weeks, China Xiangtai Food Corp., Ltd (NASDAQ – PLIN) has made an acquisition and entered into a JV—both steps prompt major forecast increases, with a price target upgrade under review.

Read more...
 
AEPT: Sales and Profit Growth Today, M&A Tomorrow?

While the industry zigs (or contracts) American Energy Partners, Inc. (OTC – AEPT) zags (grows like crazy). AEPT is enjoying record sales growth and solid profits. The whole complexion and profile, are changing and management confirmed that new M&A could be on the horizon which could take the valuation to a new level.

Read more...
 
An Underfollowed COVID-19 Treatment Player

Nascent Biotech (OTC – NBIO) is slated to release in vitro studies that demonstrate its lead candidate may have an impact in treatment of coronaviruses as Pritumumab may have the ability to interfere with the virus’ binding to target cells, thus possibly eliminating deadly effects.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 40